Altimmune Inc - Company Profile

Powered by

All the sales intelligence you need on Altimmune Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Altimmune Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Altimmune Inc.

Back to companies

Altimmune Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Altimmune Inc (Altimmune) is a clinical-stage biopharmaceutical company that develops peptide-based therapeutics for obesity and liver diseases. The company’s pipeline products include Pemvidutide, a glucagon receptor to treat obesity and metabolic dysfunction-associated steatohepatitis (MASH). Altimmune operates under the brands NasoVAX, HepTcell, EuPort, Densigen and RespirVec. The company through its subsidiaries operates in Australia, the UK, and the US. Altimmune is headquartered in Gaithersburg, Maryland, the US.

 Gain a 360-degree view of Altimmune Inc and make more informed decisions for your business Gain a 360-degree view of Altimmune Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address Suite 201S, 910 Clopper Road, Gaithersburg, Maryland, 20878
Website altimmune.com
Telephone 1 240 6541450
No of Employees 57
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange ALT (NASD)
Revenue (2024) $41,000 105% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ 7.3% (2024 vs 2023)
Market Cap* $600.1M
Net Profit Margin (2024) XYZ 54.8% (2024 vs 2023)
* As of and is in US$
View Altimmune Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Altimmune Inc premium industry data and analytics

100+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Altimmune Inc’s relevant decision makers and contact details.

50+

Catalyst Calendar

Proactively evaluate Altimmune Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Clinical Trials

Determine Altimmune Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Altimmune Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

6

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

6

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Pipeline Product: NasoVAX
Pemvidutide: Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Obesity HepTcell
ALT-702: Solid Tumor EuPort
XYZ
XYZ
XYZ
Understand Altimmune Inc portfolio and identify potential areas for collaboration Understand Altimmune Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters Altimmune Inc Roche Holding AG Eli Lilly and Co Merck & Co Inc Pfizer Inc
Headquarters United States of America Switzerland United States of America United States of America United States of America
City Gaithersburg Basel Indianapolis Rahway New York City
State/Province Maryland Basel-Stadt Indiana New Jersey New York
No. of Employees 57 112,774 50,605 75,000 75,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Jerome Durso Chief Executive Officer; Chairman; President Executive Board 2026 58
Gregory Weaver Chief Financial Officer Senior Management - 69
Robin E. Abramss Chief Legal Officer Senior Management - -
Christophe Arbet-Engels, M.D., Ph.D. Chief Medical Officer Senior Management - 64
M. Scot Roberts, Ph.D. Chief Scientific Officer Senior Management - 67
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Altimmune Inc key executives to enhance your sales strategy Gain insight into Altimmune Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?